Resistance to epidermal growth factor receptor inhibitors in non-small cell lung cancer and strategies to overcome it - Australian Medical Student Journal
Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer | Biomarker Research | Full Text
MET amplification causes EGFR-TKI resistance by activating... | Download Scientific Diagram
Hype or hope – Can combination therapies with third-generation EGFR-TKIs help overcome acquired resistance and improve outcomes in EGFR-mutant advanced/metastatic NSCLC? - ScienceDirect
Single targeting of MET in EGFR-mutated and MET-amplified non-small cell lung cancer | British Journal of Cancer
MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer | Journal of Hematology & Oncology | Full Text
Cells | Free Full-Text | Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment Strategy
Liquid biopsy uncovers distinct patterns of DNA methylation and copy number changes in NSCLC patients with different EGFR-TKI resistant mutations | Scientific Reports
奥希替尼在非小细胞肺癌靶向治疗中的获得性耐药机制| Semantic Scholar
MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregula | OTT
EMT, MET amplification, and IGF-1R confer resistance to EGFR TKIs.... | Download Scientific Diagram
Reciprocal relationship between MET amplification and T790M mutation.... | Download Scientific Diagram
Acquired Resistance to Osimertinib Plus Savolitinib Is Mediated by MET-D1228 and MET-Y1230 Mutations in EGFR-Mutated MET-Amplified Lung Cancer - ScienceDirect
EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression | Molecular Cancer | Full Text
Mechanisms and management of 3rd‑generation EGFR‑TKI resistance in advanced non‑small cell lung cancer (Review)
Frontiers | A Large Real-World Study on the Effectiveness of the Combined Inhibition of EGFR and MET in EGFR-Mutant Non-Small-Cell Lung Cancer After Development of EGFR-TKI Resistance
Overcoming MET-mediated resistance in oncogene-driven NSCLC - ScienceDirect
Common resistance mechanisms to EGFR TKIs in EGFR-mutated lung... | Download Scientific Diagram
MET amplification causes EGFR-TKI resistance by activating... | Download Scientific Diagram
Cancers | Free Full-Text | Immune Resistance and EGFR Antagonists in Colorectal Cancer
MET amplification and epithelial-to-mesenchymal transition exist as parallel resistance mechanisms in erlotinib-resistant, EGFR-mutated, NSCLC HCC827 cells | Oncogenesis
MET amplification causes EGFR-TKI resistance by activating... | Download Scientific Diagram
Targeted Therapies Expanding for MET Dysregulation in NSCLC - ILCN.org (ILCN/WCLC)
Use of liquid biopsy in monitoring therapeutic resistance in EGFR oncogene addicted NSCLC
